You are here: Home » Companies » News
Govt plans sale, registration of EV two, three wheelers without batteries
Volvo Buses India integrates with VECV in merger valued at Rs 100 cr
Business Standard

Zydus launches cheapest remdesivir at Rs 2,800 per 100 mg vial in India

Potential Covid-19 treatment drug launched under brand name Remdac in India

Topics
Coronavirus | Corona Remedies | Zydus Cadila

Vinay Umarji  |  Ahmedabad 



remdesivir, coronavirus, drugs, covid, pharma
Earlier, in June 2020, Zydus Cadila had entered into a non-exclusive agreement with Gilead Sciences Inc., to manufacture and sell Remdesivir

Pharma major (Zydus Cadila) on Thursday announced launch of what is so far India's cheapest remdesivir brand - Remdac at Rs 2800 per 100 mg lyophilized injection vial.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Thu, August 13 2020. 12:31 IST

RECOMMENDED FOR YOU

.